BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7231784)

  • 1. [Diagnostic value of copper and magnesium in hemolymphopathies and solid tumors].
    Russo N; Cipolletta L; Diadema MR; Parente A; Lonardo L
    Minerva Med; 1981 May; 72(21):1331-8. PubMed ID: 7231784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of laboratory indicators in Hodgkin's disease: preliminary results.
    Ray GR; Wolf PH; Kaplan HS
    Natl Cancer Inst Monogr; 1973 May; 36():315-23. PubMed ID: 4744591
    [No Abstract]   [Full Text] [Related]  

  • 3. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
    Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
    J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum magnesium, copper, and zinc alterations following spinal fusion.
    Tatari H; Işlekel H; Altekin E; Göçen S; Ozcan C; Ergör A
    Biol Trace Elem Res; 2001 Apr; 80(1):33-42. PubMed ID: 11393308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of subsequent solid tumors after non-Hodgkin's lymphoma: effect of diagnostic age and time since diagnosis.
    Hemminki K; Lenner P; Sundquist J; Bermejo JL
    J Clin Oncol; 2008 Apr; 26(11):1850-7. PubMed ID: 18347006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood copper and ceruloplasmin levels in hemolymphopathies. I. Malignant lymphoma].
    Tura S; Bernardi L; Baccarani M; Sanguinetti F; Branzi A
    G Clin Med; 1968 Nov; 49(11):1090-104. PubMed ID: 5757473
    [No Abstract]   [Full Text] [Related]  

  • 7. Value of ultrasound-guided core biopsy in the diagnosis of malignant lymphoma.
    de Larrinoa AF; del Cura J; Zabala R; Fuertes E; Bilbao F; Lopez JI
    J Clin Ultrasound; 2007; 35(6):295-301. PubMed ID: 17486566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Utility of the copper/zinc ratio in patients with lymphoma or acute or chronic leukemias].
    Rosas R; Poo JL; Montemayor A; Isoard F; Majluf A; Labardini J
    Rev Invest Clin; 1995; 47(6):447-52. PubMed ID: 8850142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Eight years of experience in a single institution in hematopoietic stem cell autologous transplantation in malignant hematological diseases and in solid tumors].
    Milone GA; Martínez Rolón J; Fernández II; Corrado CS; Desmery PM; Dignani MC; Juni M; Pavlovsky S
    Medicina (B Aires); 2000; 60(1):115-24. PubMed ID: 10835708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ORL manifestations in malignant hemopathies].
    Koffi-Aka V; Akon JC; Koné M; Yotio A; Ehouo F
    Rev Laryngol Otol Rhinol (Bord); 1999; 120(2):97-101. PubMed ID: 10444982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Number of siblings and the risk of lymphoma, leukemia, and myeloma by histopathology.
    Altieri A; Castro F; Bermejo JL; Hemminki K
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1281-6. PubMed ID: 16835324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment determination of isohaemagglutinin titter values in patients with malignant lymphomas and metastatic solid tumors.
    Nikolić L; Budisin Z; Jelić S
    Med Sci Monit; 2000; 6(1):63-7. PubMed ID: 11208285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exfoliative respiratory cytology in the diagnosis of leukemias and lymphomas in the lung.
    Bardales RH; Powers CN; Frierson HF; Suhrland MJ; Covell JL; Stanley MW
    Diagn Cytopathol; 1996 Mar; 14(2):108-13. PubMed ID: 8964165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemistry of copper, magnesium and sulfur in malignant tumors of the head (mouth, nose, face and ear)].
    de Jorge FB; Paiva LJ
    Rev Bras Med; 1967 Jun; 24(6):416-20. PubMed ID: 5604986
    [No Abstract]   [Full Text] [Related]  

  • 15. [Copper and magnesium in the plasma and erythrocytes in leukemic patients].
    Gekova K; Georgieva B; Arsov Ts
    Vutr Boles; 1979; 18(5):73-6. PubMed ID: 293091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of biologic tests in malignant hemopathies].
    Clément F
    Schweiz Med Wochenschr; 1983 Jul; 113(26):948-51. PubMed ID: 6612275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].
    Jakó J; Szerafin L; Nagy P
    Orv Hetil; 2005 Mar; 146(10):461-9. PubMed ID: 15835344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New cancer disease after treatment of Hodgkin's disease].
    Abrahamsen JF; Andersen A; Hannisdal E; Nome O; Kvaløy SO; Høst H; Abrahamsen AF
    Tidsskr Nor Laegeforen; 1993 Sep; 113(23):2903-5. PubMed ID: 8236191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood protein, iron and copper, and leukocyte alkaline phosphatase in lymphoma].
    Martinetto P; Neretto G; Agricola R; Pellerito R; Giovanelli E; Fassio D
    Arch Sci Med (Torino); 1980; 137(1):119-26. PubMed ID: 7458644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.